# Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd. – FDA Inspection, Mar 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/tianjin-darentang-jingwanhong-pharmaceutical-co-ltd/cf9a8a5c-015b-4e96-9e37-569ab49147b1
Source feed: FDA_Inspections

> FDA inspection 1235782 of Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd., March 22, 2024. Classification: Official Action Indicated (OAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235782
- Company Name: Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.
- Inspection Date: 2024-03-22
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0
- Enforcement Type: WARNING_LETTER

## Related Documents

- FDA Inspection 989604 - 2016-09-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/brandy-n-lepage/41e679e3-cc2a-4361-bf89-26acbd7deaf8)
- [FDA Associated Person](https://www.keypedia.com/people/karen-a-briggs/3e77d364-25ea-48c7-87f4-36f3e170bfb5)

Company: https://www.keypedia.com/companies/tianjin-darentang-jingwanhong-pharmaceutical-co-ltd/10618087-4dda-4a3c-b6b9-65fd81c65493

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
